Diagnostic and therapeutic process of neurofibromatosis type 1 and type 2
Open Access
- 24 February 2024
- journal article
- research article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 63, 168-181
Abstract
Neurofibromatosis is one of the most common genetic diseases. It is inherited in an autosomal dominant manner. It is divided into two genetically distinct subtypes, characterised by multiple skin lesions and tumours of the peripheral and central nervous system. Neurofibromatosis type 1, or Recklinghausen's disease, is the most common phakomatosis. The disease is genetically determined by a mutation of the neurofibromin- 1 gene on chromosome 17. Neurofibromatosis type 2 accounts for 3% of all cases. The disease is genetically determined - caused by a mutation of the neurofibromin-2 gene on chromosome 22. The diagnostic and therapeutic process of neurofibromatosis is a major challenge for clinicians. Given the complexity of the problem, we have reviewed the literature on the diagnostic and therapeutic possibilities of the disease.Keywords
This publication has 30 references indexed in Scilit:
- Management of Neurofibromatosis Type 2-Associated Vestibular SchwannomasOtolaryngologic Clinics of North America, 2023
- Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variantsHuman Genetics, 2021
- Spinal manifestations of Neurofibromatosis type 1Child's Nervous System, 2020
- Bevacizumab for NF2‐associated vestibular schwannomas of childhood and adolescencePediatric Blood & Cancer, 2020
- Neurofibromatosis type 12018
- Speech–language characteristics of children with neurofibromatosis type 1American Journal of Medical Genetics Part A, 2010
- Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck regionHuman Pathology, 2008
- The merlin interacting proteins reveal multiple targets for NF2 therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2008
- NF2: The wizardry of merlinGenes, Chromosomes and Cancer, 2003
- Neurofibromatosis Type 1American Journal of Medical Genetics, 2000